Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2026)
Eton Pharmaceuticals (ETON) posted EBT Margin of 6.64% for Q4 2025, up 176.33% sequentially from 8.7% in Q3 2025, and up 1103.0% YoY from 0.55% in Q4 2024.
Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported EBT Margin for 7 years, with the latest figure at 6.64% in Q4 2025.
- Quarterly EBT Margin rose 1103.0% year-over-year to 6.64% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5.7% (up 406.0% YoY) and the FY2025 annual result came in at 5.7%, up 406.0% from the prior year.
- EBT Margin climbed to 6.64% in Q4 2025 per ETON's latest filing, from 8.7% in the prior quarter.
- Over five years, EBT Margin peaked at 43.0% in Q1 2021 and troughed at 786.32% in Q3 2021.
- A 5-year average of 60.6% and a median of 8.69% in 2025 frame the typical range for EBT Margin.
- The widest YoY moves for EBT Margin: up 2358427 bps in 2021, down 25621628 bps in 2021.
- Over 5 years, EBT Margin stood at 17.05% in 2021, then slumped by 37 bps to 10.73% in 2022, then plunged by 163 bps to 6.74% in 2023, then jumped by 35 bps to 4.39% in 2024, then surged by 251 bps to 6.64% in 2025.
- According to Business Quant data, EBT Margin over the past three periods registered 6.64%, 8.7%, and 13.31% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.84 Bn | 40.18 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.21 Bn | 19.55 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.95 Bn | 18.06 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.71 Bn | 1.68 Bn | 25.41 Mn | 31.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.17% |
| Dec 31, 2025 | 6.64% |
| Sep 30, 2025 | -8.70% |
| Jun 30, 2025 | -13.31% |
| Mar 31, 2025 | -8.67% |
| Dec 31, 2024 | -4.39% |
| Sep 30, 2024 | 4.85% |
| Jun 30, 2024 | -32.92% |
| Mar 31, 2024 | -10.18% |
| Dec 31, 2023 | -6.74% |
| Sep 30, 2023 | -8.24% |
| Jun 30, 2023 | 38.00% |
| Mar 31, 2023 | -50.15% |
| Dec 31, 2022 | 10.73% |
| Sep 30, 2022 | -60.90% |
| Jun 30, 2022 | -31.16% |
| Mar 31, 2022 | -244.94% |
| Dec 31, 2021 | 17.05% |
| Sep 30, 2021 | -786.32% |
| Jun 30, 2021 | -65.73% |